SCHEMBL23558433

SCHEMBL23558433

O=C1CC(CO)(CO)Oc2ccc(-c3cc(-c4cccc(O)c4)no3)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 1/20 0.51
▸ HSD17B2 P37059 1/20 0.51
▸ NPC1 O15118 5/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ MLLT1 Q03111 5/20 0.38
▸ MAPT P10636 4/20 0.38
▸ HSD17B13 Q7Z5P4 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ MAPK1 P28482 3/20 0.38
▸ TP53 P04637 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ HPGD P15428 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ MLLT3 P42568 1/20 0.36
▸ ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23558568 0.90 HSD17B1 (0.46) HSD17B1HSD17B2NPC1RAB9AMAPT
SCHEMBL23558481 0.85 RAB9A (0.42) HSD17B1HSD17B2NPC1RAB9AMAPT
SCHEMBL23558442 0.85 S1PR1 (0.42) HSD17B1HSD17B2NPC1RAB9AMAPT
SCHEMBL23558493 0.84 TPH1 (0.41) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL23558589 0.82 NPC1 (0.33) HSD17B1HSD17B2NPC1RAB9AMAPT
SCHEMBL25856900 0.80 MAOB (0.43) HSD17B1HSD17B2NPC1RAB9AMAPT
SCHEMBL23558330 0.80 RAB9A (0.40) HSD17B1HSD17B2NPC1RAB9AMAPT
SCHEMBL25863238 0.80 CXCR1 (0.40) HSD17B1HSD17B2NPC1RAB9AALDH1A1
SCHEMBL23558461 0.79 NPC1 (0.45) HSD17B1HSD17B2NPC1RAB9AMEN1
SCHEMBL23558404 0.78 ABCB1 (0.51) NPC1RAB9AKMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2023-07-27 — — US disclosed
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 HSD17B1 2149/4885HSD17B2 2368/4885NPC1 301/4885
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 HSD17B1 2149/4885HSD17B2 2368/4885NPC1 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback